Skip to main navigation Skip to search Skip to main content

Monitoring the genetic testing and life insurance moratorium in Australia: A national research project

Research output: Contribution to journalComment / DebateOtherpeer-review

Abstract

Genetic discrimination in life insurance is a long-standing issue in Australia. In July 2019, an industry self-regulated moratorium removed the equirement for Australian consumers to disclose genetic test results to life insurance companies on policies up to A$500,000. Although the moratorium is an important step, concerns remain around the financial limits, terms, public awareness, lack of government oversight and compliance monitoring. The impact and adequacy of the moratorium needs evaluation to inform the planned 2022 review. A new research project has been funded by the MRFF Genomic Health Futures Mission, which aims to monitor the efficacy of the moratorium.
Original languageEnglish
Pages (from-to)157-159.e1
Number of pages10
JournalMedical Journal of Australia
Volume214
Issue number4
DOIs
Publication statusPublished - Mar 2021

Keywords

  • Ethics
  • Research design

Cite this